financetom
Business
financetom
/
Business
/
'Blade Runner 2049' producer sues Tesla, Warner Bros over AI images
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
'Blade Runner 2049' producer sues Tesla, Warner Bros over AI images
Oct 22, 2024 12:48 PM

Oct 21 (Reuters) - Movie and television studio Alcon

Entertainment on Monday sued Tesla and Warner Bros

Discovery ( WBD ) over claims they used images tied to the film

"Blade Runner 2049" to promote Tesla's new autonomous cybercab.

Alcon's California federal lawsuit alleged violations of

U.S. copyright law and accused Tesla of "false endorsement" for

suggesting a relationship between Alcon and the Elon Musk-owned

electric vehicle maker.

"Any prudent brand considering any Tesla partnership has to

take Musk's massively amplified, highly politicized, capricious

and arbitrary behavior, which sometimes veers into hate speech,

into account," the lawsuit said.

Tesla and Warner Bros did not immediately respond to

requests for comment.

Warner Bros was Alcon's distributor for "Blade Runner 2049",

which won two 2018 Academy Awards and starred Ryan Gosling and

Harrison Ford in the highly anticipated sequel to the 1982 cult

classic Blade Runner.

Alcon said it had refused a request from Warner Bros to use

images from the firm for Tesla's Oct. 10 live-streamed cybercab

unveiling. Tesla then used images created with artificial

intelligence that mirrored the movie for its cybercab event, the

lawsuit said.

In a statement, Alcon said the defendants' "conduct is

likely to cause confusion among Alcon's 'Blade Runner' brand

partner customers, including those it is partnering with for its

upcoming 'Blade Runner 2099' series for Amazon Prime."

The lawsuit did not name specific damages but said Alcon had

spent hundreds of millions of dollars building the Blade Runner

2049 brand, and said the "financial magnitude of the

misappropriation here was substantial."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft expands availability of its AI-powered cybersecurity assistant
Microsoft expands availability of its AI-powered cybersecurity assistant
Mar 13, 2024
March 13 (Reuters) - Microsoft ( MSFT ) will widen the availability of its artificial intelligence-powered tool for cybersecurity professionals from April 1 and adopt a 'pay-as-you-go' strategy for the assistant, the company said on Wednesday. Soft-launched last year, 'Security Copilot' lets analysts run queries through a simple prompt box to help with tasks like summarizing incidents, analyzing vulnerabilities and...
National Bank on Thomson Reuters' Investor Day 2024
National Bank on Thomson Reuters' Investor Day 2024
Mar 13, 2024
12:53 PM EDT, 03/13/2024 (MT Newswires) -- After outlining its 2024-2026 guidance on February 8, Thomson Reuters ( TRI ) held its triennial Investor Day to help explain the steps being taken to achieve its outlook which involves a year of greater investment in 2024 ahead of an acceleration in organic growth and renewed margin expansion, notes National Bank. Analyst...
Infosys Seen Confident in 20% to 22% EBIT Margin Target on Project Maximus, Wedbush Says
Infosys Seen Confident in 20% to 22% EBIT Margin Target on Project Maximus, Wedbush Says
Mar 13, 2024
12:53 PM EDT, 03/13/2024 (MT Newswires) -- Infosys ( INFY ) management is confident in achieving the targeted earnings before interest and taxes margin range of 20% to 22%, supported by internal project Maximus bolstering a five-tier strategy, Wedbush said Wednesday in a report. Delayed 2024 budgets indicate a stronger H2, especially in digital project, and recent cost-saving efforts such...
Ginkgo Bioworks Collaborating With Dutch Biotech ProteoNic to Extend Proteins Production, Genetic Therapies
Ginkgo Bioworks Collaborating With Dutch Biotech ProteoNic to Extend Proteins Production, Genetic Therapies
Mar 13, 2024
12:51 PM EDT, 03/13/2024 (MT Newswires) -- Ginkgo Bioworks ( DNA ) is collaborating with ProteoNic Biosciences through a new strategic partnership that will provide Ginkgo customers with access to the Dutch biotech's protein production platform and other cell and gene therapy applications, the companies said Wednesday. As part of the partnership, ProteoNic will join Ginkgo's technology network bringing together...
Copyright 2023-2026 - www.financetom.com All Rights Reserved